All Bausch + Lomb articles – Page 2
-
News briefs
Papa to step down as Bausch+Lomb CEO
Bausch + Lomb has announced that Joseph C. Papa had stepped down from his position of chairman of the company’s board of directors and that it was searching for a new CEO to replace him in his executive role. Until a successor is appointed, Papa will remain as CEO and ...
-
ArticleEyewear companies stocks down by 17% in Q2
Contrary to other sectors such as energy, aerospace, defense or agriculture, which saw their stock value increase significantly in the last few months, the eyewear industry was not among the beneficiaries from the move of global money away from investments in Big Tech companies. Indeed, the 23 eyewear public companies ...
-
News briefs
B+L expands its board
Bausch + Lomb (B+L) has expanded its board of directors by two seats and filled them with Brett Icahn and Gary Hu, both from Carl C. Icahn and affiliates (Icahn Group). B+L has entered into an amended and restated Director Appointment and Nomination Agreement with Icahn Group, after the distribution ...
-
ArticleBausch + Lomb sees earnings squeezed in Q1, confirms FY sales guidance
Bausch + Lomb reported an adjusted Ebitda of $170 million in the first quarter of 2022, down from $198 million the year earlier, as growth in organic revenues was more than offset by foreign currency headwinds and the negative impact from new Covid-19 lockdowns in China. For the full year, ...
-
ArticleBausch + Lomb sees 5% organic sales growth in Q1 as IPO wraps up
Bausch Health sold 35 million common Bausch + Lomb shares, or a 10.0 percent stake, at a price of $18.00 per share, in an initial public offering yielding gross proceeds of $630 million and valuing its subsidiary at about $6,300 million. Joseph Papa, chairman of Bausch Health and CEO of ...
-
News briefs
Bausch + Lomb to be spun off in IPO
Bausch Health Companies is spinning off Bausch + Lomb Corporation. The announcement came on April 28 that Bausch + Lomb would be making an initial public offering of 35.0 million common shares on the New York Stock Exchange (NYSE) and the Toronto Stock Exchange (“TSX”), under the ticker symbol BLCO ...
-
ArticleRussian contact lenses market in turmoil
Russia experiences a temporary shortage of Johnson & Johnson’s Acuvue contact lenses due to panic buying and logistics disruptions, the Russian newspaper Kommersant reported, quoting optical retailers. The Russian retail chain Happy Look said that Acuvue accounted for 50 percent of the Russian contact lenses market, and from 70 to ...
-
News briefs
Bausch + Lomb to contract $2.7 bn loan before IPO
Bausch Heatlh has announced that its subsidiary Bausch + Lomb was looking into securing a new credit agreement ahead of its Initial Public Offering (IPO), scheduled to take place in the course of this year. The company is seeking to contract a $2.5 billion term B loan and an additional ...
-
ArticleSales of contact lenses in Europe rebound slightly over 2019 level
Euromcontact, the European federation of national associations and international contact lens manufacturers, calculated that the market value for soft contact lenses at wholesale level increased by 14.3 percent year-on-year to €1,991 million last year in the 34 countries researched. The list includes mostly European countries but also the U.A.E., Egypt, ...
-
News briefs
Bausch + Lomb sees 6% Q4 sales gain ahead of planned IPO
The Bausch + Lomb unit of Bausch Health saw revenues in the fourth quarter of 2021 increase by 6 percent compared to the year earlier to $1,001 million. Revenues were 7 percent higher at constant currency rates, reflecting the continued positive impacts of recovery from the Covid-19 pandemic. Reported sales ...
-
ArticleBausch Health files for IPO of its eyecare business
In its quest to split into three publicly traded companies, Bausch Health has filed to make an initial public offering of common shares in the U.S. and most of Canada for its wholly owned subsidiary Bausch + Lomb Corporation. Specifically, it has filed a Registration Statement with the U.S. Securities ...
-
News briefs
B+L has recycled more than 41 million contact lenses
Bausch + Lomb (B+L) says that its “One by One” and “Biotrue Eye Care Recycling” programs have processed 41,358,603 units, or 248,516 pounds, of used contact lenses and other eye- and lens-care materials. One by One deals with contact lenses, which are typically too small for standard recyclers to handle ...
-
News briefs
Bausch + Lomb's contact lenses sales up 6 % in Q3
Bausch Health has announced a 4 percent year-on-year hike in Q3 revenues for its Bausch + Lomb unit to $949 million. In constant currencies, quarterly sales were up by 3 percent as compared to the same period last year, primarily because of the positive impacts of the recovery from the ...
-
News briefs
Google hails the inventor of the soft contact
Last Wednesday’s Google “Doodle” – the search engine’s ever-changing commemorative logo illustration – paid tribute to Otto Wichterle, the Czech chemist who held about 180 patents and invented the soft contact lens. This Oct. 27 was his 108th birthday. Wichterle was born in Prostějov, in what was then the Austro-Hungarian ...
-
News briefs
Bausch + Lomb Q2 sales up 33%
Bausch Health reported a year-on-year increase of 38 percent to $934 million in quarterly revenues for its Bausch + Lomb (B + L) unit. In constant currencies, B + L Q2 sales grew by 33 percent from the same period in 2020. The unit’s revenue growth was driven ...
-
News briefs
B + L invests €90m in Irish plant
Bausch + Lomb announced last week a €90 million investment plan to expand its factory in Waterford, Ireland, in order to boost its production capacity for the Biotrue ONE day contact lenses’ range. The construction is expected to start in 2023 and to generate an additional 130 jobs ...
-
ArticleBausch gears up to spin off B+L
As part of its quarterly results’ announcements, Bausch Health said that it was accelerating the preparations for the spin-off of its Bausch + Lomb business. Having just completed its financial segmentation of the unit, the company said it expects to be ready for the operation in Q3 2021. ...
-
News briefs
Bausch Health might sell Bausch+Lomb, rather than spin it off
Quoting sources close to the matter, Bloomberg News reported last week that Bausch Health was currently exploring the possibility of a sale of its Bausch+Lomb ’s eye care business unit, instead of the initially planned spin-off. Before being renamed as Bausch Health, Valeant Pharmaceuticals International had acquired ...
-
News briefs
Bausch Health appoints new CFO, prepares B+L spin off
The Canadian healthcare company Bausch Health announced the appointment of Paul Herendeen , its chief financial officer since 2016, to the newly created position of advisor to the chairman and CEO of the company, starting June 1. Herendeen’s CFO responsibilities will be transferred to Sam Eldessouky , who joined ...
-
ArticleThe European soft contact lenses’ market decreased by 9% last year
The European wholesale market for soft contact lenses decreased by 9.1 percent year-on-year to €1,376 million in 2020 according to data collected in 13 countries by Euromcontact, the European federation of national associations and international contact lenses manufacturers. The countries included in this research are: Belgium, Luxemburg, Denmark, France, Germany, ...
- Previous Page
- Page1
- Page2
- Page3
- Next Page
